Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-23

Clinical Trial Update: Investigating Dupilumab's Effect in Asthma by Genotype [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating dupilumab's effects in asthma by genotype. The study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dupilumab (dupilumab)

Snippet

Sponsor: Boston Children's Hospital | Conditions: Asthma | Phase 4 | Status: ACTIVE_NOT_RECRUITING